Amgen Inc. (AMGN) News Today: Latest Market and Industry Updates

436.87
2.0900
0.48 %
Daily range
Weekly range
  • Anton Kharitonov
  • 19 hours ago
Amgen stock climbs while resistance at $447.12 approaches
Amgen Inc. (AMGN) stock is trading at $438.43, up 3.17% on the day. The stock sits above its short-, medium-, and long-term moving averages, reflecting bullish ...
  • Ashutosh Sureka
  • 15.10.2026
Why is Amgen stock up 3.3% today?
Amgen Inc. (AMGN) surged 3.36% after increasing investor interest on late-stage clinical trial success and strong institutional activity drove fresh demand. The move is supported by persistent ...
  • Viktoras Karapetjanc
  • 22.09.2026
Amgen stock breakout attempt: Upside targets to watch
Amgen Inc. (AMGN) stock is trading at $407.42, gaining 3.5% on the day. The price is positioned above its key moving averages, reflecting continued strength in recent ...
  • Jainam Mehta
  • 22.09.2026
Amgen study met its primary endpoint after stock ends session up 2%
Amgen announced that a Phase 3 study of its investigational therapy for patients with moderate-to-severe Sjogren’s disease activity reached its primary endpoint on September 7, 2026. Separately, ...
  • Andrey Mastykin
  • 08.09.2026
AMGN slides as selloff dominates the short-term trend
Amgen (AMGN) stock is trading at $397.01, marking a decline of 9.19% on the day. The price sits below its key moving averages, indicating continued short-term selling ...
  • Mykhailo Ihnatenko
  • 08.09.2026
Amgen announces Phase 3 DLL3-therapy study met primary endpoint as stock falls 7.5%
Amgen announced on August 21, 2026, that a Phase 3 trial evaluating its DLL3-targeting therapy as part of first-line maintenance for extensive-stage small cell lung cancer met its primary ...
  • Sholanke Dele
  • 19.08.2026
Amgen stock price prediction: Double-digit sales growth strengthens rally outlook
Amgen Inc. (AMGN) stock is trading at $442.51, posting a strong daily gain of 4.02%. The price is positioned above its key short- and long-term moving averages, ...
  • Sholanke Dele
  • 05.08.2026
Amgen stock resistance test: Breakout levels to watch
Amgen Inc. (AMGN) stock is trading at $413.76, up 4.72% on the day. The price is holding well above its key moving averages and near the session high, with firm intraday ...
  • Sholanke Dele
  • 04.08.2026
Amgen stock slides 1.64 percent to $378.89 as price tests crucial $378.22 support
Amgen is set to report its second-quarter 2026 financial results tomorrow, the company said. At the same time, Amgen stock is down 1.6% on the day at $378.89.Amgen, through its official account, ...
  • Sholanke Dele
  • 31.07.2026
Amgen edges higher to $387.77 ahead of Q2 2026 results announcement, Amgen reports
Amgen will report its Q2 2026 financial results on Tuesday, according to Amgen.The company posted a link for further details. The stock trades under the ticker AMGN.[highlights-block]Bullish ...
  • Ashutosh Sureka
  • 29.07.2026
Amgen stock rallies toward 52-week high after CHMP positive opinion for cardiovascular drug
Amgen said it received a positive opinion today from the EMA's Committee for Medicinal Products for Human Use as an important step towards expanding treatment options for adults at high ...
  • Jainam Mehta
  • 28.07.2026
FDA receives additional data for Tavneos lifts Amgen stock toward $402.79 resistance
Amgen Inc. (AMGN) stock is trading at $392.5 after rising 4.36% today. The price is above its key short- and medium-term moving averages, confirming a strong position ...
  • Jose Antonio Gastelum
  • 25.07.2026
Amgen stock gains 1.23% as Amgen features in new MrBeast video amid bullish momentum
Amgen appears in MrBeast's newest video, the company said in a tweet.The video showcases Amgen, MrBeast, Stand Up To Cancer, and partners working to bring attention to the need for pediatric ...
  • Ezequiel Gomes
  • 24.06.2026
Amgen edges higher to $347.82 as it joins HHS roundtable on clinical trial access
Amgen expressed appreciation to the U.S. Department of Health and Human Services for organizing a Clinical Trials Roundtable.The company said clinical trials are key to bringing new medicines to ...
  • Parshwa Turakhiya
  • 17.06.2026
Amgen stock consolidates near $348 amid robust Research Triangle growth
Amgen is investing more than $1.5 billion in North Carolina's life sciences ecosystem, the company said on social media.Amgen says the investment contributes to innovation, growth, and opportunity ...
  • Dan Blystone
  • 11.06.2026
+3.35% for Amgen stock as Gilpin, ING Groep NV, Motley Fool increase holdings
Amgen Inc. (AMGN) stock is trading at $349.04, up 3.35% today. The price currently sits above its key moving averages, reflecting momentum in the current ...
  • Andreas Kristo
  • 08.06.2026
Amgen stock extends rally above $349 with bullish momentum and overbought signals
Amgen shared new data on cardiometabolic care at the #ADASciSessions 2026, the company said in a tweet.Amgen said the data reinforce the need for more integrated approaches to prevention, risk ...
  • Dan Blystone
  • 04.06.2026
Amgen stock rises 3.05 percent as Amgen leadership explores AI-driven innovation in drug development
Amgen CEO Bob Bradway appeared on Bain and Company's Winning with AI podcast alongside Sarah Elk and AI pioneer Andrew Ng, the company said in a tweet.The discussion covered how AI is accelerating ...
  • Emilio Ghigini
  • 03.06.2026
Amgen stock climbs as obesity drug research boosts future pipeline
Amgen Inc. (AMGN) stock is trading at $338.42, up 3.09% today. The price currently sits above its short- and long-term moving averages, indicating support from these ...
  • Dan Blystone
  • 03.06.2026
Amgen stock edges higher to $330.51 as new data in rare autoimmune diseases presented, Amgen announces
Amgen announced the presentation of new data across rare autoimmune and inflammatory diseases at EULAR2026.The research covers IgG4-related disease and real-world evidence in ANCA-associated ...
  • Parshwa Turakhiya
  • 01.06.2026
Amgen shares dip amid rising selling pressure
Amgen Inc. (AMGN) is trading at $329.33, representing a daily decline of $7.56 or 2.24%. The asset remains just above its 200-day simple moving average ($328.23), while positioned below both the ...